Bank of New York Mellon Corp Makes New Investment in Nordson Corporation $NDSN

Key Points

• Bank of New York Mellon initiated a sizable Nordson position, purchasing 421,723 shares worth approximately $127.2 million, or about 0.76% of the company. Institutional investors collectively own 72.11% of NDSN.
• Nordson exceeded quarterly expectations, reporting $3.25 in EPS and $817.7 million in revenue, with revenue up 10.3% year over year. Management guided fiscal 2026 EPS to $11.80–$12.00, while analysts maintain a “Moderate Buy” consensus and an average price target of $326.57.
• The stock opened at $332.24 and trades at roughly 33.6 times earnings; its $0.82 quarterly dividend equates to a 1.0% annual yield. Reported insider selling and the elevated valuation could increase downside risk if growth momentum weakens.

Bank of New York Mellon Corp purchased a new stake in Nordson Corporation (NASDAQ:NDSN - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 421,723 shares of the industrial products company's stock, valued at approximately $127,230,000. Bank of New York Mellon Corp owned approximately 0.76% of Nordson at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of NDSN. Focus Partners Advisor Solutions LLC acquired a new stake in Nordson during the 2nd quarter valued at $452,000. Clearstead Trust LLC acquired a new position in shares of Nordson in the second quarter worth $25,000. USA Financial Formulas raised its holdings in shares of Nordson by 538.1% in the first quarter. USA Financial Formulas now owns 2,750 shares of the industrial products company's stock worth $732,000 after acquiring an additional 2,319 shares during the last quarter. Oppenheimer Asset Management Inc. purchased a new stake in shares of Nordson in the second quarter valued at $2,092,000. Finally, Bryn Mawr Trust Advisors LLC purchased a new stake in shares of Nordson in the second quarter valued at $439,000. 72.11% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently commented on NDSN shares. BNP Paribas Exane lifted their price objective on Nordson from $285.00 to $290.00 and gave the stock a "neutral" rating in a research report on Friday, May 22nd. Robert W. Baird upped their target price on shares of Nordson from $328.00 to $351.00 and gave the company a "neutral" rating in a report on Friday. Weiss Ratings raised shares of Nordson from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Monday, June 29th. KeyCorp reiterated a "buy" rating on shares of Nordson in a report on Thursday. Finally, DA Davidson reiterated a "buy" rating and issued a $345.00 price target on shares of Nordson in a report on Thursday. Five investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $326.57.

Nordson Price Performance

NDSN opened at $332.24 on Monday. The company's 50 day simple moving average is $298.83 and its 200 day simple moving average is $287.14. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.18 and a current ratio of 1.82. Nordson Corporation has a 1 year low of $220.06 and a 1 year high of $338.55. The stock has a market capitalization of $18.51 billion, a PE ratio of 33.59, a P/E/G ratio of 2.17 and a beta of 0.96.

Nordson (NASDAQ:NDSN - Get Free Report) last issued its quarterly earnings results on Wednesday, August 19th. The industrial products company reported $3.25 EPS for the quarter, topping the consensus estimate of $3.09 by $0.16. The firm had revenue of $817.67 million during the quarter, compared to analyst estimates of $779.49 million. Nordson had a net margin of 18.63% and a return on equity of 20.49%. Nordson's revenue for the quarter was up 10.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.73 earnings per share. Nordson has set its FY 2026 guidance at 11.800-12.000 EPS. As a group, sell-side analysts expect that Nordson Corporation will post 11.8 EPS for the current year.

Nordson Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, July 6th. Investors of record on Thursday, June 18th were issued a $0.82 dividend. The ex-dividend date was Thursday, June 18th. This represents a $3.28 dividend on an annualized basis and a yield of 1.0%. Nordson's dividend payout ratio (DPR) is presently 33.16%.

Key Stories Impacting Nordson

Here are the key news stories impacting Nordson this week:

• Positive Sentiment: Strong Q3 beat and broad-based growth: Nordson reported adjusted earnings of $3.25 per share, above the $3.09 consensus and up from $2.73 a year earlier. Revenue reached $817.7 million, exceeding estimates of $779.5 million and increasing 10.3% year over year. Record sales across all segments, stronger orders and broad organic growth supported the results. NDSN Q3 Earnings Beat Estimates on Broad Organic Growth
• Positive Sentiment: Higher fiscal 2026 outlook: Management raised its outlook for the third time, forecasting fiscal 2026 sales of $3.035 billion to $3.075 billion and adjusted EPS of $11.80 to $12.00. Backlog reportedly increased 35%, reinforcing expectations for continued demand and earnings momentum. Nordson Forecasts Fiscal 2026 Sales and EPS
• Positive Sentiment: Analyst price-target increases: Oppenheimer raised its target from $335 to $370 and upgraded its view to “outperform.” Robert W. Baird lifted its target from $328 to $351 while maintaining a “neutral” rating. DA Davidson reaffirmed its “buy” rating with a $345 target. Analysts Boost Forecasts on Nordson
• Neutral Sentiment: New medical product: Nordson MEDICAL introduced its Divert ULTRA line of ultra-high-pressure stopcocks for demanding medical applications. The launch expands the product portfolio but was not accompanied by a specific financial impact. Nordson MEDICAL Introduces Divert ULTRA
• Negative Sentiment: Insider selling and valuation: Reported insider activity showed 46 sales and no purchases over the past six months, including sizable sales by senior executives. After the rally, Nordson trades at roughly 33.6 times earnings, leaving the stock vulnerable to profit-taking if growth or guidance momentum slows.

Nordson Profile

Nordson Corporation designs, manufactures and markets precision dispensing equipment and systems that apply adhesives, coatings, sealants and polymers in a broad range of industrial and medical applications. The company's portfolio spans fluid systems, curing and surface preparation technologies, vacuum and thermal management products, and advanced test and inspection solutions. Nordson's offerings serve critical manufacturing processes by delivering exacting dispensing accuracy and process control to ensure consistent product performance and high production throughput.

Nordson operates through multiple segments that cater to diverse markets including electronics, packaging, medical, energy, automotive and general industrial sectors.

Want to see what other hedge funds are holding NDSN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nordson Corporation (NASDAQ:NDSN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source